Clinical Impact of Baseline ctDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Clinical Impact of Baseline ctDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.
Authors: Yamada, Takeshi1 (AUTHOR) y-tak@nms.ac.jp, Nagasaka, Takeshi2 (AUTHOR), Matsuhashi, Nobuhisa3 (AUTHOR), Takahashi, Takao4 (AUTHOR), Hirata, Keiji5 (AUTHOR), Nakamura, Yuki6 (AUTHOR), Sugimoto, Kiichi7 (AUTHOR), Koda, Keiji8 (AUTHOR), Hiramatsu, Kazuhiro9 (AUTHOR), Matsuoka, Hiroshi10 (AUTHOR), Kuramochi, Hidekazu11 (AUTHOR), Matsuda, Akihisa1,12 (AUTHOR), Ishida, Hideyuki12,13 (AUTHOR), Kataoka, Kozo13,14 (AUTHOR), Yokomizo, Hajime14,15 (AUTHOR), Kagawa, Yoshinori15,16 (AUTHOR), Suenaga, Mitsukuni1,16 (AUTHOR), Yoshida, Hiroshi1,2 (AUTHOR)
Source: Cancers. Jun2026, Vol. 18 Issue 11, p1688. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18111688